Dhanvantri Jeevan Rekha Ltd Stock Analysis

BSE: 531043 | NSE: | Hospital & Healthcare Services | Small Cap

BSE Share Price 07-Feb-2023 17:29
13.47 -0.70 (-4.94%)

DeciZen - Make an Informed Decision on DhanvantriJeevan Rek

M-Cap below 100cr DeciZen not available

DhanvantriJeevan Rek Price Chart

P/E Ratio ( SA) :
Market Cap :
5.8 Cr.
52-wk low :
52-wk high :
Bole Toh?

1. Is Dhanvantri Jeevan Rekha Ltd a good quality company?

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Dhanvantri Jeevan Rekha Ltd is a below average quality company.

2. Is Dhanvantri Jeevan Rekha Ltd undervalued or overvalued?

The key valuation ratios of Dhanvantri Jeevan Rekha Ltd's currently when compared to its past seem to suggest it is in the Fair zone.

3. Is Dhanvantri Jeevan Rekha Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Dhanvantri Jeevan Rekha Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of DhanvantriJeevan Rek:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Dhanvantri Jeevan Rekha Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation

Value Creation Index Colour Code Guide

ROCE % 14.3%8.7%13.8%11.3%10.1%7.8%1.1%-2.2%-14.3%5.4%-
Value Creation Index 0.0-0.4-0.0-0.2-0.3-0.4-0.9-1.2-2.0-0.6-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 5.87.389.311.213.716.818.29.816.817
YoY Gr. Rt. %-26.3%9.8%16.2%20.6%23%22.5%8.2%-46.3%71.4%-
YoY Gr. Rt. %--33.7%77.9%-3.7%-10.7%-14.4%-93.8%-681.8%NANA-
BVPS (₹) 14.816.120.522.824.125.92625.421.923.122.6
Adj Net Profit 0.80.6110.90.70.1-0.3-1.40.50
Cash Flow from Ops.
Debt/CF from Ops. 0.10.10002.20.10.1-0.20-


CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales 12.6%8.5%-0.1%71.4%
Adj EPS -5.8%-10.4%121.8%NA
BVPS 5.1-0.9-3.95.5
Share Price 10.1% -16.6% 18.5% -24.1%

Key Financial Parameters

Performance Ratio Colour Code Guide

Return on Equity % 14.78.713.
Op. Profit Mgn % 25.918.319.215.614.413.57.33.7-
Net Profit Mgn % 14.67.712.410.
Debt to Equity 000000.200000
Working Cap Days 62531251741228271631077285
Cash Conv. Cycle 2520232412122017323124

Recent Performance Summary

Sales growth is good in last 4 quarters at 25.82%

Return on Equity is Poor

Sales growth has been subdued in last 3 years -0.14%

Latest Financials - Dhanvantri Jeevan Rekha Ltd.

Standalone Consolidated
TTM EPS (₹) -0.4 -
TTM Sales (₹ Cr.) 17 -
BVPS (₹.) 22.6 -
Reserves (₹ Cr.) 5 -
P/BV 0.63 -
PE 0.00 -
From the Market
52 Week Low / High (₹) 9.30 / 19.55
All Time Low / High (₹) 3.69 / 61.70
Market Cap (₹ Cr.) 5.8
Equity (₹ Cr.) 4.1
Face Value (₹) 10
Industry PE 60

Management X-Ray of DhanvantriJeevan Rek :

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *
* Pledged shares as % of Promoter's holding (%)

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of DhanvantriJeevan Rek

Adj EPS (Rs.)
Sales (Cr.)
ROE (%)
ROCE (%)


Dhanvantri Jeevan Rekha Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of DhanvantriJeevan Rek on 07-Feb-2023 17:29 is : 13.47.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 07-Feb-2023 17:29 the market cap of DhanvantriJeevan Rek stood at ₹ 5.81.
The latest PE ratio of DhanvantriJeevan Rek as of 07-Feb-2023 17:29 is 0.00.
The latest PB ratio of DhanvantriJeevan Rek as of 07-Feb-2023 17:29 is 0.63
The 52-week high of DhanvantriJeevan Rek is ₹ 19.55 and the 52-week low is ₹ 9.30.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue / sales of DhanvantriJeevan Rek is ₹ 17.01 ( Cr.) .

About Dhanvantri Jeevan Rekha Ltd

Dhanvantri Jeevan Rekha, incorporated on June 11, 1993 is a multi speciality hospital providing reliable diagnostic and therapeutical services. We lay great emphasis on providing good nursing care and clean environment. Dhanvantri hospital has been on the fore front of providing state of art equipment and services in western UP since 1994.

It offers diagnostic and therapeutic facilities in all specialities, well equipped multidisciplinary intensive care units and cashless hospitalization for accredited patients.

The company is basically engaged in offering different medical facilities like Cardiac Care, Endourology, Gastroenterology, Neuro Surgery, Neurology, Anestheslogy and Orthopedic Surgery.

The company was incorporated as a Public Limited Company with the Registrar of Companies in Uttar Pradesh with the main object of providing diagnostic and therapeutic services including Magnetic Resonance Imaging  (MRI). The company obtained certificate for commencement of business on August 2, 1993. The company was incorporated  with an authorized capital of Rs. 200 Lacs which was subsequently increased to Rs. 500 Lacs from time to time.

In the month of October 1993 the company acquired a constructed building at 1, Saket, Meerut for establishing the Diagnostic Centre. The renovation of the site has already been completed. Diagnostic equipments in the Urology and Cardiology Sections have already been installed and are in operation. The company has acquired the adjacent plot in 2004 on which the future expansion plan is expected to commence shortly.

Services offered by the company:

  • Female Urology
  • Impotency
  • Infertility
  • Lithotripsy
  • Paediatric Urology
  • Cystometrogram
  • Uroflowmetry
  • Uro Oncology 
  • Uro Lithiasis
  • Stricture Urethra
  • Renal Transplant & Dialysis

Future plans :

  • A 100 bedded new wing
  • 30 bedded ICU.
  • Multislice spiral CT scan. 
Read More Read Less
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login | Register Now